Shyft Analytics, a Waltham, MA-based provider of analytics cloud for life sciences, secured a $7.5m investment.
The investment from Optum Ventures closed out a strategically-lead $20m Series B Round of funding that included McKesson and Medidata Solutions. Along with the investment, Optum Ventures will join SHYFT’s Board of Directors.
The company intends to use the funds to further advance its healthcare cloud analytics solutions in the areas of Real World Evidence (RWE), Specialty Pharma, and Rare Disease.
Led by Zack King, CEO and Founder, Shyft Analytics provides an analytics cloud for life sciences that enables companies to catalyze clinical development and commercial growth through converged insights.
The company serves customers in oncology, cardiovascular disease, diabetes, specialty, rare disease and biotechnology sectors.